Australia markets closed

Factor Therapeutics Limited (FTT.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
0.00500.0000 (0.00%)
At close: 10:02AM AEST
Currency in AUD

Valuation measures

Market cap (intra-day) 55.21M
Enterprise value 32.01M
Trailing P/E ∞
Forward P/E 1N/A
PEG ratio (5-yr expected) 1N/A
Price/sales (ttm)7.81
Price/book (mrq)1.67
Enterprise value/revenue 33.02
Enterprise value/EBITDA 76.71

Trading information

Stock price history

Beta (5Y monthly) 0.55
52-week change 3100.00%
S&P500 52-week change 349.51%
52-week high 30.0070
52-week low 30.0020
50-day moving average 30.0050
200-day moving average 30.0050

Share statistics

Avg vol (3-month) 3N/A
Avg vol (10-day) 3N/A
Shares outstanding 51.04B
Implied shares outstanding 6N/A
Float 501.99M
% held by insiders 124.80%
% held by institutions 10.77%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:1
Last split date 304 Feb 2009

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2020
Most-recent quarter (mrq)31 Dec 2020


Profit margin 42.24%
Operating margin (ttm)44.43%

Management effectiveness

Return on assets (ttm)5.80%
Return on equity (ttm)9.31%

Income statement

Revenue (ttm)667.61k
Revenue per share (ttm)0.00
Quarterly revenue growth (yoy)16.20%
Gross profit (ttm)855.02k
EBITDA 300.27k
Net income avi to common (ttm)281.99k
Diluted EPS (ttm)0.0000
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)3.2M
Total cash per share (mrq)0
Total debt (mrq)N/A
Total debt/equity (mrq)N/A
Current ratio (mrq)38.56
Book value per share (mrq)0.00

Cash flow statement

Operating cash flow (ttm)166.66k
Levered free cash flow (ttm)64.14k